Market Overview

11 Biggest Mid-Day Losers For Tuesday

Share:
  • Avinger Inc (NASDAQ: AVGR) shares plummeted 51.56 percent to $0.77, after having soared on April 10.
  • Cytori Therapeutics Inc (NASDAQ: CYTX) shares slid 35.47 percent to $1.11, after the company priced a stock offering at a huge discount. Cytori’s shares had surged on April 10, after the company announced FDA approval for its burn clinical trial.
  • DryShips Inc. (NASDAQ: DRYS) shares plunged 26.81 percent to $1.82. The company announced that it had reached an agreement with Sifnos Shareholders Inc. to amend the Revolving Facility Agreement.
  • AmTrust Financial Services Inc (NASDAQ: AFSI) shares plummeted 21.75 percent to $14.77, following unconfirmed reports of accounting problems at the company allegedly dating back to 2009.
  • Hub Group Inc (NASDAQ: HUBG) shares slid 14.07 percent to $40.60, after the company issues a profit warning and projected its diluted EPS for Q1 at $0.30-$0.32.
  • Sito Mobile Ltd (NASDAQ: SITO) shares fell 13.78 percent to $2.69.
  • XCel Brands Inc (NASDAQ: XELB) shares plummeted 14.04 percent to $2.45.
  • Birks Group Inc (NYSE: BGI) shares declined 9.09 percent to $1.50.
  • Transcontinental Realty Investors Inc (NYSE: TCI) shares slid 13.71 percent to $10.07. The company reported its Q4 net income at $3.2 million, or $0.37 per share, and full-year net loss of $0.9 million, or ($0.10) per share.
  • Naked Brand Group Inc (NASDAQ: NAKD) shares were down 12.18 to $2.17. The company announced that it had 2,189,052 shares of common stock at an average price of $2.51 to raise ~$5.3 million in net proceeds under the “At The Market Offering Agreement” with Maxim Group.
  • MTS Systems Corporation (NASDAQ: MTSC) shares declined 10.18 percent to $48.33.

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets General

 

Related Articles (AFSI + AVGR)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial

Net-Sold Stocks In Record-Setting March

Looking For The Positives In TherapeuticsMD's Recently Received FDA Letter